Bio-Techne
TECH
#1477
Rank
S$15.49 B
Marketcap
$97.65
Share price
0.40%
Change (1 day)
-2.76%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): S$1.56 B

According to Bio-Techne's latest financial reports the company's current revenue (TTM) is S$1.50 B. In 2023 the company made a revenue of S$1.51 B an increase over the revenue in the year 2022 that were of S$1.50 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) S$1.56 B3.35%
2023 S$1.51 B0.73%
2022 S$1.50 B8.12%
2021 S$1.38 B31.45%
2020 S$1.05 B5.48%
2019 S$1.00 B7.83%
2018 S$0.92 B15.84%
2017 S$0.80 B4.88%
2016 S$0.76 B16.07%
2015 S$0.65 B22%
2014 S$0.53 B29.01%
2013 S$0.41 B9.43%
2012 S$0.38 B-3.71%
2011 S$0.39 B13%
2010 S$0.35 B-5.58%
2009 S$0.37 B-3.61%
2008 S$0.38 B11.84%
2007 S$0.34 B6.32%
2006 S$0.32 B1.98%
2005 S$0.31 B28.4%
2004 S$0.24 B-5.03%
2003 S$0.26 B9.23%
2002 S$0.23 B5.91%
2001 S$0.22 B20.03%
2000 S$0.18 B15.46%
1999 S$0.16 B24.72%
1998 S$0.13 B21.98%
1997 S$0.10 B32.58%
1996 S$80.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
S$55.15 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.33 B 121.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.82 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.49 B 1,720.87%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.52 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$80.64 B 5,241.83%๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.14 M-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA